Impact of the timing of hepatitis B virus identification and anti–hepatitis B virus therapy initiation on the risk of adverse liver outcomes for patients receiving cancer therapy
Jessica P. Hwang; Maria E. Suarez‐Almazor; Scott B. Cantor; Andrea Barbo; Heather Y. Lin; Sairah Ahmed; Mariana Chavez‐MacGregor; Christian Donato‐Santana; Cathy Eng; Alessandra Ferrajoli; Michael J. Fisch; Peter McLaughlin; George R. Simon; Gabriela Rondon; Elizabeth J. Shpall; Anna S. Lok
Author Information: Department of General Internal Medicine
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.